Priority Driven Collaborative Cancer Research Scheme Priority-driven (PDCCRS) 2009: Randomised Collaborative Cancer Peter MacCallum phase III trial to assess Peter MacCallum Cancer $124,666.67 23/05/2013 42 3002 Australia Cancer Centre response adapted therapy Cancer Centre Research using PET in newly diagnosed Scheme advanced Hodgkin Lymphoma. Appl ID: 628842 Priority Driven Collaborative Cancer Research Scheme Priority-driven (PDCCRS) 2008: RNA Loading Collaborative of Tumour Associated Cancer University of Cancer Antigens and the Activation $327,195 23/05/2013 74 University of Sydney 2006 Australia Sydney Research of Blood Dendritic Cells for Scheme Prostate Cancer Immunotherapy: Appl ID: 543713 Priority-driven Priority Driven Collaborative Collaborative Cancer Research Scheme Cancer University of Cancer (PDCCRS) 2012: Solving $599,381 01/06/2013 61 Parkville 3010 Australia Melbourne Research Unknown Primary cancER – Scheme SUPER. Appl ID 1048193. Priority Driven Collaborative Cancer Research Scheme Priority-driven (PDCCRS) 2012: Accelerating Collaborative First-Line Chemotherapy to Cancer University of Cancer Improve Cure Rates for $252,583.48 01/06/2013 50 University of Sydney 2006 Australia Sydney Research Advanced Germ Cell Scheme Tumours: An Australian-Led, International Randomised Trial. Appl ID 1041733 Priority Driven Collaborative Cancer Research Scheme Priority-driven (PDCCRS) 2012: Adding Collaborative Cancer University of mitomycin C to intravesical Cancer $457,143.17 01/06/2013 58 University of Sydney 2006 Australia Sydney BCG for high-risk, Research bladder cancer: a Scheme randomised phase 3 trial. Appl ID 1041651 Priority Driven Collaborative Priority-driven Cancer Research Scheme Collaborative Queensland (PDCCRS) 2012: Germline Cancer Cancer Institute of Medical Copy Number Variants are $24,420.50 01/06/2013 19 Herston 4028 Australia Research Research Genetic Risk Factors for Scheme Familial Colorectal Cancer. Appl ID 1052035
Cancer Australia Priority-driven Collaborative Cancer Research Scheme Peter MacCallum Cancer Centre Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Randomised phase III trial to assess response adapted therapy using PET in newly diagnosed advanced Hodgkin Lymphoma. Appl ID: 628842 $124,666.67 23/05/2013 42 Peter MacCallum Cancer Centre 3002 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Sydney Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: RNA Loading of Tumour Associated Antigens and the Activation of Blood Dendritic Cells for Prostate Cancer Immunotherapy: Appl ID: 543713 $327,195 23/05/2013 74 University of Sydney 2006 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Melbourne Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Solving Unknown Primary cancER – SUPER. Appl ID 1048193. $599,381 01/06/2013 61 Parkville 3010 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Sydney Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Accelerating First-Line Chemotherapy to Improve Cure Rates for Advanced Germ Cell Tumours: An Australian-Led, International Randomised Trial. Appl ID 1041733 $252,583.48 01/06/2013 50 University of Sydney 2006 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Sydney Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Adding mitomycin C to intravesical BCG for high-risk, bladder cancer: a randomised phase 3 trial. Appl ID 1041651 $457,143.17 01/06/2013 58 University of Sydney 2006 Cancer Australia Priority-driven Collaborative Cancer Research Scheme Queensland Institute of Medical Research Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Germline Copy Number Variants are Genetic Risk Factors for Familial Colorectal Cancer. Appl ID 1052035 $24,420.50 01/06/2013 19 Herston 4028
grants_reporting_20170703.docx